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Sirtuin1 protects endothelial 
Caveolin-1 expression and 
preserves endothelial function 
via suppressing miR-204 and 
endoplasmic reticulum stress
M. Kassan1, A. Vikram1, Y. R. Kim1, Q. Li1, A. Kassan2, H. H. Patel3, S. Kumar1, M. Gabani1, 
J. Liu1, J. S. Jacobs1 & K. Irani1
Sirtuin1 (Sirt1) is a class III histone deacetylase that regulates a variety of physiological processes, 
including endothelial function. Caveolin1 (Cav1) is also an important determinant of endothelial 
function. We asked if Sirt1 governs endothelial Cav1 and endothelial function by regulating miR-204 
expression and endoplasmic reticulum (ER) stress. Knockdown of Sirt1 in endothelial cells, and in vivo 
deletion of endothelial Sirt1, induced endothelial ER stress and miR-204 expression, reduced Cav1, 
and impaired endothelium-dependent vasorelaxation. All of these effects were reversed by a miR-204 
inhibitor (miR-204 I) or with overexpression of Cav1. A miR-204 mimic (miR-204 M) decreased Cav1 
in endothelial cells. In addition, high-fat diet (HFD) feeding induced vascular miR-204 and reduced 
endothelial Cav1. MiR-204-I protected against HFD-induced downregulation of endothelial Cav1. 
Moreover, pharmacologic induction of ER stress with tunicamycin downregulated endothelial Cav1 
and impaired endothelium-dependent vasorelaxation that was rescued by overexpressing Cav1. In 
conclusion, Sirt1 preserves Cav1-dependent endothelial function by mitigating miR-204-mediated 
vascular ER stress.
Sirt1 belongs to the sirtuin family of nicotinamide adenine dinucleotide (NAD+ )-dependent protein 
deacetylases, whose activation protects against cardiovascular diseases1,2. Sirt1 promotes endothelium-dependent 
vascular relaxation by activating endothelial nitric oxide synthase3. Caveolin 1 (Cav1) is expressed in the plasma 
membrane caveolae of the endothelial cells and has an important role in the regulation of vascular function4. 
Additionally, a recent report indicates that Cav1 is a direct binding partner of Sirt1 in mouse embryonic 
fibroblasts5.
MicroRNAs (miRNAs) are short non-coding RNAs that regulate target gene expression in a 
post-transcriptional manner. More than 16 miRNAs modulate Sirt1 expression6. MicroRNA regulation of Sirt1 
might affect a wide variety of pathways in humans, from metabolic diseases such as diabetes to cardiovascular dis-
eases and cancer6. Vascular miR-204 impaired endothelial dependent vasorelaxation by downregulation of Sirt17.
Several miRNAs have been reported to regulate the ER stress response, either through specific targets or 
through mechanisms that are yet unclear8. Recently, it has been shown that miR-204 is implicated in the ER stress 
responsive gene modulation and apoptosis in cancer9,10. Additionally, miR-211, which shares an almost identical 
sequence with miR-204, has been reported to be induced in a PERK-dependent manner11. Moreover, ER stress 
reduces Cav112 and overexpression of Cav1 mitigates ER stress in prostate cancer cells13. In addition, in renal 
cancer cells Cav1 has been shown to be a target of miR-20414. However, the relation between miR-204 and Cav1 
in endothelial cells is yet to be determined.
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Given this background and the known role of Sirt1 in endothelium-dependent vascular function, we explored 
if lack of Sirt1 downregulates Cav1 and produces endothelial dysfunction through induction of ER stress and 
miR-204.
Results
Endothelial Sirt1 protects Cav1 expression by downregulating miR-204. To study the effect 
of Sirt1 on vascular Cav1 and miR-204, we generated mice conditionally lacking endothelial Sirt1 (eSirt1−/−). 
Endothelial miR-204 was upregulated, and Cav1 is downregulated, in both thoracic aortas and mesenteric resist-
ance arteries of eSirt1−/− mice (Fig. 1A–D). To determine if down-regulation of Cav1 in eSirt1−/− mice is due to 
miR-204, miR-204 inhibitor (miR-204 I) was transfected ex vivo into both thoracic aortas and mesenteric resist-
ance arteries of eSirt1−/− mice, resulting in suppression of miR-204 expression (Fig. 1A,C). MiR-204 I rescued 
Cav1 (Fig. 1B,D).
We also determined if Sirt1 regulates Cav1 expression in human umbilical vein endothelial cells (HUVECs) 
in vitro. SiRNA-mediated knockdown of Sirt1 downregulated Cav1 in HUVECs (Fig. 1E). Further, miR-204 I res-
cued Cav1 expression (Fig. 1E). Taken together, these findings show that Sirt1 protects endothelial Cav1 expres-
sion by suppressing miR-204.
MiR-204 downregulates endothelial Cav1. We next determined the effect of miR-204 on endothelial 
Cav1 expression, independent of Sirt1. HUVECs were transfected with a miR-204 mimic oligonucleotide (miR-
204 M). MiR-204 mimic (miR-204 M) suppressed Cav1 protein (Fig. 2A) and mRNA (Fig. 2B), suggesting that 
Figure 1. Sirt1 supports endothelial Cav1 expression via downregulation of miR-204. In situ hybridization 
for miR-204 (A,C) and immunofluorescence for Cav1 (B,D) in thoracic aorta (A,B) and mesenteric 
resistance arteries (MRA) (C,D) of eSirt1−/− and Sirt1flx/flx mice systemically infused with miR-204 inhibitor 
oligonucleotide (miR-204 I) or scrambled control oligonucleotide (miR SC). Quantification of endothelial Cav1 
is shown below immunofluorescence images. Red arrows point to miR-204. *p < 0.05 between eSirt1−/− + miR 
SC vs. Sirt1flx/flx + miR SC, Sirt1flx/flx + miR-204 I and eSirt1−/− + miR-204 I. #p < 0.05 between eSirt1−/− + miR-
204 I vs. Sirt1flx/flx + miR SC, Sirt1flx/flx + miR-204 I. (E) Immunoblots for Sirt1 and Cav1 in HUVEC transfected 
with siRNA for Sirt1 or scrambled control siRNA (siRNA SC), and miR-204 I or miR SC. Data is representative 
of three independent experiments and densitometric quantification shown on right. *p < 0.05 between miR 
SC + siRNA Sirt1 vs. miR SC + siRNA SC, miR-204 I + siRNA SC and miR-204 I + siRNA Sirt1. #p < 0.05 
between miR-204 I + siRNA Sirt1 vs. miR SC + siRNA SC, miR-204 I + siRNA SC.
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miR-204 targets Cav1 at the post-transcriptional level. We also asked if miR-204 is responsible for Cav1 downreg-
ulation in a pathophysiological model of endothelial dysfunction. High fat diet (HFD) feeding of C57Bl/6 mice 
leads to obesity and endothelial dysfunction, bu not atherosclerosis. Immunofluorescence for Cav1 in thoracic 
aortas of C57Bl/6 mice on a HFD demonstrated reduction of endothelial Cav1 (Fig. 2C). In addition, systemic 
infusion of miR-204 I in HFD-fed mice rescued endothelial Cav1 expression (Fig. 2C). These finding underscore 
the important role of miR-204 in downregulating endothelial Cav1 in a pathophysiological model of endothelial 
dysfunction.
Cav1 rescues impaired endothelium-dependent vasorelaxation due to lack of Sirt1. We asked if 
downregulation of Cav1 observed in eSirt1−/− mice is responsible for impaired endothelium-dependent vasore-
laxation in these mice. To answer this question, we reconstituted Cav1 ex vivo in aortas and MRA of eSirt1−/− mice 
using a recombinant adenovirus (AD Cav1) (Fig. 3A,B). Endothelium-dependent vasorelaxation was impaired 
in aortas and MRA of eSirt1−/− mice compared to aortas and MRA from control Sirt1flx/flx mice (Fig. 3C,D). 
Importantly, reconstitution of Cav1 restored normal endothelium-dependent vasorelaxation in eSirt1−/− mice 
(Fig. 3C,D). However, Cav1 overexpression in vessels from Sirt1flx/flx mice in which endothelial function is nor-
mal, paradoxically led to marked impairment of endothelium-dependent vasorelaxation (Fig. 3C,D). These 
findings underscore that normal endothelial function maintained by Sirt1 is mediated through Cav1, but also 
highlight that excessive Cav1 expression in the vasculature is deleterious for endothelial function.
ER stress downregulates endothelial Cav1 through miR-204. MiR-204 has been implicated in pro-
moting endoplasmic reticulum stress in other tissues8,9,15. Because ER stress is associated with endothelial dys-
function16, we explored the relationship between endothelial Cav1, miR-204, and ER stress. BiP, a marker of 
ER stress, was induced in aortas and MRA of eSirt1−/− mice (Fig. 4A,B). In addition, the protein glycosylation 
inhibitor tunicamycin (Tun), a pharmacologic stimulant of ER stress, downregulated Cav1 in HUVECs and in 
MRA of mice in vivo (Fig. 4C,D) while increasing miR-204 expression in MRA (Fig. 4F). To establish a causal role 
for miR-204 in ER stress-induced downregulation of vascular Cav1, we systemically infused mice with miR-204 
I. Tunicamycin-induced downregulation of vascular Cav1 was partially abrogated in MRA of mice that received 
miR-204 I compared to those that didn’t (Fig. 4E). These data demonstrate that upregulation of vascular miR-204 
is responsible for ER stress-induced downregulation of Cav1.
Figure 2. MiR-204 downregulates endothelial Cav1. Immunoblot with quantification on right (A) and qPCR 
(B) for Cav1 in HUVECs transfected with miR-204 mimic (miR-204 M) or miR SC. Data is representative 
of three independent experiments. *p < 0.05 between miR-204 M vs. miR SC (C) Immunofluorescence with 
quantification on right for Cav1 in aortas of mice subjected to high fat diet-feeding for 12 weeks (HFD), and 
systemically infused with miR-204 I or miR SC. ND: normal chow diet. *p < 0.05 between HFD + miR SC vs. 
ND + miR SC, ND + miR-204 I and HFD + miR-204 I. #p < 0.05 between HFD + miR-204 I vs. ND + miR SC 
and ND + miR-204 I.
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Cav1 protects against ER stress-induced endothelial dysfunction. We then asked if downregulation 
of vascular Cav1 is responsible for endothelial dysfunction due to ER stress. Cav1 was reconstituted ex-vivo using 
AD Cav1 in aortas and MRA from mice treated with tunicamycin (Fig. 5A,D). Reconstitution of Cav1 mitigated 
vascular ER stress (BiP expression) in aortas and MRA (Fig. 5B,E), and partially rescued endothelium-dependent 
vasorelaxation in aortas and MRA of mice treated with tunicamycin (Fig. 5C,F). However, similar to our prior 
observation, overexpression of Cav1 in aortas and MRA from mice not treated with tunicamycin (Veh), led to 
marked impairment of endothelium-dependent vasorelaxation (Fig. 5C,F).
Discussion
The present study sheds new light on the complex relationship between vascular Sirt1, miR-204, ER stress and 
Cav1 in the context of vascular endothelial function. Our data show that lack of Sirt1 is associated with ER stress 
and induction of miR-204, which is responsible for downregulation of Cav1. Downregulation of Cav1, in turn, 
contributes to impairment of endothelium-dependent vasorelaxation in both conductance and resistance arteries.
Sirt1 plays a salutary role in the endothelium by deacetylating eNOS, thus stimulating eNOS-derived 
NO3. Our data suggests that in addition to directly regulating eNOS activity, Sirt1 may also indirectly govern 
eNOS-derived NO by regulating the expression of modulators of eNOS activity such as Cav1. The role of Cav1 in 
vascular function is complex. On the one hand, Cav1 has been traditionally considered to suppress eNOS acti-
vation by binding to its calcium/calmodulin site and preventing its translocation and phosphorylation17,18. On 
Figure 3. Cav1 rescues endothelial dysfunction due to lack of Sirt1. Immunofluorescence for Cav1 in 
aortas (A) and mesenteric resistance arteries (MRA) (B) of mice with conditional deletion of endothelial 
Sirt1 (eSirt1−/−) and control Sirt1flx/flx mice, infected ex vivo with adenovirus expressing Cav1 (AD Cav1) 
or control adenovirus expressing LacZ (AD LacZ). Quantification of endothelial Cav1 is shown below 
immunofluorescence images. *p < 0.05 between eSirt1−/− + AD LacZ vs. Sirt1flx/flx + AD LacZ, Sirt1flx/flx  
+ AD Cav1 and eSirt1−/− + AD Cav1. #p < 0.05 between Sirt1flx/flx + AD Cav1 vs. Sirt1flx/flx + AD LacZ, and 
eSirt1−/− + AD Cav1. Endothelium-dependent relaxation in thoracic aortas (C) and MRA (D) of eSirt1−/− and 
Sirt1flx/flx mice, infected ex vivo with AD Cav1 or AD LacZ. *p < 0.05 between eSirt1−/− + AD LacZ vs. Sirt1flx/flx  
+ AD LacZ, Sirt1flx/flx + AD Cav1 and eSirt1−/− + AD Cav1. #p < 0.05 between Sirt1flx/flx + AD Cav1 vs. 
eSirt1−/− + AD LacZ, Sirt1flx/flx + AD LacZ, or eSirt1−/− + AD Cav1.
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the other hand, constitutive lack of Cav1 leads to super-physiologic levels of NO, with generation of secondary 
NO-derived reactive species such as peroxynitrite18, a culprit well-known to impair endothelial function. Thus, 
Sirt1-regulated Cav1 expression may achieve a sweet spot whereby Cav1 levels are sufficient to curtail NO pro-
duction, while not excessive to suppress maintenance levels of NO. Supporting this contention is our experimen-
tal data that restoring Cav1 in aortas and MRA of mice subjected to ER stress rescued endothelium-dependent 
vasorelaxation, whereas overshooting Cav1 expression in vessels of mice not subjected to ER stress impaired 
endothelium-dependent vasorelaxation (Fig. 5A,C,D and F).
It is noteworthy that oxidative stress in mouse embryonic fibroblasts promotes sequestration of Sirt1 in cave-
olae through direct binding to Cav1, resulting in suppression of Sirt1 activity5. This finding, taken together with 
our data that Sirt1 is required for Cav1 expression, suggests a negative feedback loop for the fine tuning of Cav1 
expression. As indicated above, such modulation of Cav1 expression may be especially important in the endothe-
lium faced with oxidative stresses (such as ER stress) where, as our data suggests, either a significant decline or 
upregulation of Cav1 impair function.
Sirt1 expression is governed by microRNAs7. MiR-204 targets Sirt1 in non-vascular tissues19,20. In addition, 
recent evidence shows that miR-204 targets endothelial Sirt1, thereby leading to endothelial dysfunction7. Out 
data indicates that loss of Sirt1 in endothelial cells leads to upregulation of miR-204. Moreover, miR-204 func-
tions as a mediator to suppress Cav1 expression in Sirt1 deficient/depleted endothelial cells and vascular tissue. 
Consistent with our results, miR-204 downregulates Cav1 in renal clear cell carcinoma14. Whether this suppres-
sion is direct or indirect is not clear, and will require further experimentation.
ER stress plays a key role in vascular endothelial dysfunction16. Moreover, several studies have reported a 
link between ER stress and decline of Sirt1 in other tissues21,22, though none have shown this in the vasculature. 
Figure 4. ER stress downregulates endothelial Cav1 through miR-204. Immunofluorescence for ER 
stress marker BiP in thoracic aorta (A) and MRA (B) from eSirt1−/− and Sirt1flx/flx mice. *p < 0.05 between 
eSirt1−/− vs. Sirt1flx/flx. Quantification of endothelial BiP is shown at bottom. Immunoblots (C) for Cav1 qPCR 
(D) for Cav1 in HUVECs treated with Tunicamycin (Tun) or vehicle (Veh). Quantification of immunoblots 
is shown at bottom. Data is representative of three independent experiments. ^p < 0.05 between Tun vs. Veh. 
(E) Immunofluorescence for Cav1 in MRA of C57Bl/6 mice treated with tunicamycin (Tun) for 2 weeks with 
systemic infusion of miR-204 I or miR SC. @p < 0.05 between miR SC + Tun vs. miR SC + Veh, miR-204 
I + Veh and miR-204 I + Tun. %p < 0.05 between miR-204 I + Tun vs. miR SC + Veh and miR-204 I + Veh. 
(F) In situ hybridization for miR-204 in MRA of C57Bl/6 mice treated with tunicamycin for 2 weeks when 
compared to mice treated with vehicle.
www.nature.com/scientificreports/
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Figure 5. Cav1 rescues ER stress-induced endothelial dysfunction. Immunofluorescence for Cav1 with 
quantification on right (A,D), and ER stress marker (BiP) with quantification on right (B,E), and endothelium-
dependent vasorelaxation (C,F) in thoracic aortas (A,B,C) and MRA (D,E,F), of C57Bl/6 mice treated with 
tunicamycin (Tun) or vehicle control (Veh). and infected ex vivo with AD Cav1 or AD LacZ. *p < 0.05 between 
Tun + AD LacZ vs. Veh + AD LacZ, Veh + AD Cav1 and Tun + AD Cav1. #p < 0.05 between Veh + AD Cav1 
vs. Veh + AD LacZ and Tun + AD Cav1. ^p < 0.05 between Tun + AD Cav1 vs. Veh + AD Cav1 and Veh + AD 
LacZ. Yellow arrows point to BiP expression in the endothelium.
www.nature.com/scientificreports/
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Additionally, our findings indicate that ER stress is associated with reduction in Cav1, and are in accordance 
with a study in human endothelial cells which showed that Cav1 is reduced in an ER stress–dependent manner12. 
Additional studies have shown that Cav1 overexpression rescues thapsigargin-induced ER stress and apoptosis in 
prostate cancer cells13 and support our findings relating to decrease in endothelial ER stress by overexpression of 
Cav1. Furthermore, studies show a role for miR-204 in the ER stress–responsive gene modulation and apoptosis 
in certain cancer cell types9,10 which is consistent with our findings that miR-204 plays a vital part in the ER stress 
response in endothelial cells.
Finally, our data regarding the role of miR-204 in downregulating vascular Cav1 in a high-fat diet feeding 
model of obesity support studies showing that obesity in humans and in experimental models is associated with 
downregulation of Sirt123–26 and Cav118,27, and upregulation of miR-2047 in various tissues (Fig. 6).
Research Design and Methods
Animals. Experiments were performed on 8–12 week-old (1) C57Bl/6 mice and (2) mice with conditional 
deletion of endothelial Sirt1 (eSirt1−/−). The eSirt1−/− mice were generated by crossing Sirt1flx/flx mice with cad-
herin-5-Cre mice, in which the Cre recombinase is driven by an endothelium-specific cadherin-5 promoter. 
Sirt1flx/flx mice were used as controls. Mice were fed standard chow (Research Diets Inc., New Brunswick, NJ) 
containing (in kilocalories) 10% fat, 70% carbohydrate, and 20% protein (D12450B). Terminal experiments were 
performed after mice were anesthetized (2–5% isoflurane). The thoracic aorta and the mesenteric resistance 
arteries (MRAs) were isolated and used for immunoblotting, immunostaining, in situ hybridization (ISH), real-
time quantitative polymerase chain reaction (qPCR), and vascular reactivity. All protocols were approved by the 
Institutional Animal Care and Use Committee of the University of Iowa. All methods were performed in accord-
ance with the guidelines and regulation of the University of Iowa.
In vivo induction of ER stress by tunicamycin. Tunicamycin (Calbiochem, San Diego, CA USA) was 
dissolved in dimethyl sulfoxide (DMSO) and injected intraperitoneally at the dose of 0.75 mg/kg, two injections 
per week for 2 weeks into mice as previously described28. DMSO alone was used as vehicle in control mice.
High fat (Western) diet. Mice were fed a HFD (Envigo, TD.88137) for 12 weeks. Mice fed with normal diet 
(ND) were used as controls.
In vivo inhibition of miR-204. Locked nucleic acid miR-204 inhibitor (5′ -AGG ATG ACA AAG GGA-3′ ; 
miR-204 I) or a scrambled nucleotide (5′ -ACG TCT ATA CGC CCA-3′ ; miR SC) (Ambion Life Technologies, Grand 
Island, NY, USA) was systemically infused into mice using ALZET osmotic pumps that were implanted subcuta-
neously. Mice treated with tunicamycin were infused with miR-204 I or miR SC for 2 weeks (0.2 mg/week/mouse). 
HFD and ND mice were infused with miR-204 inhibitor or scrambled nucleotide for 6 weeks (0.7 mg/kg/day).
Ex vivo infections with adenoviruses and transfections with a miR-204 inhibitor. MiR-204 I, 
miR SC, AD LacZ and AD Cav1 were transfected/infected into freshly isolated thoracic aortas and mesenteric 
resistance arteries (MRAs) from mice. Oligonucleotides were mixed with oligofectamine followed by addition to 
the medium. After 4 h, vascular rings were moved to fresh medium and further incubated for 24 h. Adenoviruses 
were directly added to the medium and incubated for 24 h.
Figure 6. Schematic summarizing the main findings in this paper. 
www.nature.com/scientificreports/
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Mouse vascular reactivity. Male mice 8–12 weeks old were anesthetized and euthanized by rapid car-
diac excision. The thoracic aorta and the MRAs were carefully harvested and placed in ice-cold Krebs buffer 
(118.3 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 25 mM NaHCO3, 1.2 mM MgSO4, 11 mM glu-
cose, 0.0026 mM CaNa2 EDTA). Vessels were cleaned of fat and connective tissue, and cut transversely into 5–10 
rings (1.8–2.0 mm wide). Vessels rings were placed in oxygenated chambers (95% O2/5% CO2) filled with 5 mL 
Krebs buffer solution and maintained at 37 °C and pH 7.4. Each ring was suspended between two wire stirrups in 
a 5 mL organ chamber of a four-chamber myograph system (DMT). One stirrup was connected to a three–dimen-
sional micromanipulator and the other to a force transducer. The contractile force was recorded electronically. 
All rings were stretched to 2000 mg in 500 mg increments over a 1 h period to optimize the contractile response 
to KCl. One dose of KCl (60 mM) was added to verify vascular smooth muscle viability. Endothelium-dependent 
vasodilatation was determined by generating dose–response curves to acetylcholine (ACh) (10−9 to 3.10−5 M) 
in rings pre-constricted with phenylephrine (10−6 M) and was also expressed as percent maximal contraction.
Immunostaining. Aortic and mesenteric arteries sections were de-paraffinized with xylene, followed by 
antigen retrieval by heating in citrate buffer (10 mM). Sections were probed with appropriate primary antibod-
ies. Sirt1 antibody (Santa Cruz Biotech, Dallas, TX), Caveolin-1, Binding immunoglobulin protein (BiP), von 
Willebrand factor antibody (Abcam, Cambridge, MA) were used at a 1:50 to 1:200 dilution followed by a bioti-
nylated secondary antibody for immunofluorescence. Sections were digitally imaged with an Olympus BX-61 
microscope.
Western blotting. Immunoblotting was performed in lysate from thoracic aorta and MRAs as previously 
described29. Chemiluminescent signal was developed using the Licor Odyssey Scanner (Lincoln, NE, USA). 
Bands were quantified using image J.
In situ hybridization for miR-204. Aortic and MRA sections were de-paraffinized with xylene, followed 
by Proteinase K treatment (10 μ g/mL for 5 min). ISH buffer (Exiqon, Vedbaek, Denmark; production #90000) 
was added with miR-204 probe (Exiqon, 5′ -Dig-N-AGG CAT AGG ATG ACA AAG GGA A-N-Dig-3′ ) or with a 
scramble-miR probe (Exiqon, 5′ -Dig-N-GTG TAA CAC GTC TAT ACG CCC A-N-Dig-3′ ) at 20 nM or 40 nM, 
and incubated for 72 h at 56 °C. After washing, the vessel sections were incubated in blocking solution for 15 min 
(5 mL PBS + 50 mg BSA + 100 uL Sheep serum + 2.5 uL Tween 20), followed by incubation with anti-DIG-FAB 
overnight (1:800 in antibody dilution solution). Slides were dipped in a solution containing BCIP/NBT (Roche, 
Mannheim, Germany) and incubated at 30 °C for 48 h. The slides were mounted with DPX and observed under 
the microscope.
Cell culture, plasmid/siRNA transfections, and adenoviral infections. Human umbilical vein 
endothelial cells (HUVECs) were purchased from Clonetics (San Diego, CAUSA) and cultured in endothelial 
growth medium (EGM-2, Lonza, Walkersville, MD, USA). Cells were treated with tunicamycin (Tun, 1 μ g/mL for 
6 h). Cells were transfected with plasmids, miR-204 mimica (5′ -UUC CCU UUG UCA UCC UAU GCC U-3′ ), 
miR-204 inhibitor (5′ -AGG ATG ACA AAG GGA-3′ ) or scrambled miR (5′ -ACG TCT ATA CGC CCA- 3′ ), val-
idated siRNA-Sirt1, or negative control siRNA purchased from Invitrogen with Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA). Cells were infected with 2 × 108 viral particles per milliliter (VP/ml) of the control AD LacZ or the 
AD Cav1 and incubated at 37 °C for 24 h.
QPCR. Total RNA was isolated by the acid guanidinium thiocyanate/phenol/chloroform method. Total RNA 
from cultured cells was isolated by the TRIZOL (Invitrogen) method. Real-time PCR was performed using the 
Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA) with the SuperScript III Platinum 
SYBR Green One-Step qRT-PCR Kit (Invitrogen). The following primers (Exiqon) were used. Human GAPDH: 
forward 5′ -ATG ACA TCAAGAAGGTGGTG-3′ ; reverse 5′ -CATACCAGGAAATGAGCTTG-3′ . Human Cav1 
forward 5′ -CTAATCCAAGCA TCCCTTTGCC-3′ , reverse 5′ -TTTATTACTGCCTCCTCCCCCA-3′ . Human 
GAPDH (Quanta Biosciences, Beverly, MA, USA) was used as internal controls for mRNA quantification.
Statistical analysis. Statistical analysis was performed using GraphPad Prism (Version 6.0) statistical soft-
ware (GraphPad Software, Inc., San Diego, CA, USA). Significance of difference between two groups was eval-
uated using the t-test. For multiple comparisons, one-way analysis of variance (ANOVA) was used and post-hoc 
analysis was performed with Tukey’s test. Date are expressed as mean ± SEM and considered significant if 
P-values were ≤ 0.05. All shown data is representative of at least three independent experiments.
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